These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33586497)

  • 1. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxidase expression is decreased by palmitate in cultured podocytes but increased in podocytes of advanced diabetic nephropathy.
    Lee E; Lee HS
    J Cell Physiol; 2018 Dec; 233(12):9060-9069. PubMed ID: 30132841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitate induces mitochondrial superoxide generation and activates AMPK in podocytes.
    Lee E; Choi J; Lee HS
    J Cell Physiol; 2017 Dec; 232(12):3209-3217. PubMed ID: 28214337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
    Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grem2 mediates podocyte apoptosis in high glucose milieu.
    Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
    Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
    Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
    Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
    Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
    Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 17. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
    Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
    Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
    Korbut AI; Taskaeva IS; Bgatova NP; Muraleva NA; Orlov NB; Dashkin MV; Khotskina AS; Zavyalov EL; Konenkov VI; Klein T; Klimontov VV
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.
    Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X
    J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.